Key facts
- This page summarizes Steve E. Krognes's Form 4 filing for Denali Therapeutics Inc. (DNLI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jun 2023, 18:07.
Steve E. Krognes - 01 Jun 2023 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)
- Reporting relationship
- Director
- Issuer ticker
- DNLI
- Reported as of
- 01 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Jun 2023, 18:07:43 UTC
- Prior SEC filing
- 15 Feb 2023
- Next SEC filing
- 16 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tyler Nielsen, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve E. Krognes filed Form 4 for Denali Therapeutics Inc. (DNLI) on 05 Jun 2023.
Change
- Previous filing in this sequence was filed on 15 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNLI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,216
- Change %
- +2.9%
- Price
- $0.000000
- Shares after
- 147,218
- Date
- 01 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2
DNLI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 850,000
- Date
- 01 Jun 2023
- Ownership
- See footnote
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNLI
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +12,649
- Change %
- Price
- $0.000000
- Shares after
- 12,649
- Date
- 01 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,649
- Exercise price
- $30.92
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Footnote F2
Includes 36,502 unvested RSUs.
Footnote F3
The shares are held of record by The Steve Edward Krognes Revocable Trust U/A DTD 01/25/2016, for which the Reporting Person serves as trustee.
Footnote F4
100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.